Lung Cancer News and Research

Latest Lung Cancer News and Research

New combination MRI-ultrasound imaging system improves treatment for prostate cancer patients

A new combination MRI-ultrasound imaging system can result in fewer biopsies and better treatment decisions for prostate cancer patients.

10 Feb 2014

Two oncogenes work together to sustain population of cells in lung squamous cell carcinoma

Patients with a common form of lung cancer — lung squamous cell carcinoma — have very few treatment options. That situation may soon change.

10 Feb 2014

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, and Merck's investigational anti-PD-1 immunotherapy, MK-3475, in a Phase I/II study in previously treated metastatic and recurrent non-small cell lung cancer (NSCLC), and other advanced or metastatic cancers.

5 Feb 2014

Splicing findings offer lung cancer clues

Researchers from Spain have identified several new splicing events regulated by the oncogenic splicing factor SRSF1 in lung cancer, suggesting that their dysregulation is involved in the pathogenesis of the disease.

4 Feb 2014

Primary tumor, node location important in stage III NSCLC prognosis

Researchers from Japan say that classifying clinical mediastinal lymph node status based on the location of the primary tumor and the node involved could improve prognosis in stage III non-small-cell lung cancer compared with pathologic node status.

3 Feb 2014

Study describes new tack in treatment of lung adenocarcinomas

The most common genetic subtype of lung cancer, which has long defied treatment with targeted therapies, has had its growth halted by a combination of two already-in-use drugs in laboratory and animal studies, setting the stage for clinical trials of the drugs in patients, researchers at Dana-Farber Cancer Institute and other scientists report in a new study.

31 Jan 2014

TSRI scientists awarded grant to develop new therapeutic approaches for lung cancer

Scientists from the Florida campus of The Scripps Research Institute have been awarded approximately $1.8 million from the National Cancer Institute of the National Institutes of Health to identify the signaling pathways that underlie lung cancer and to use this information to develop new therapeutic approaches.

30 Jan 2014

American Cancer Society, SU2C partner to fight against cancer

The American Cancer Society, the largest voluntary health organization in the world dedicated to eliminating cancer, and Stand Up To Cancer, the charitable initiative supporting groundbreaking research aimed at getting new treatments to patients in an accelerated timeframe, announced today an historic collaboration in the fight against cancer, which takes more than 585,000 lives in the U.S. each year and nearly 8 million worldwide.

30 Jan 2014

New pre-clinical data shows potential protective effects of GFT505 in different types of cancer

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.

30 Jan 2014

EORTC study evaluates health-related quality of life assessment in small-cell lung cancer

An EORTC study published in Lancet Oncology found that health-related quality of life assessment in small-cell lung cancer randomized clinical trials provides relevant added information in studies where the treatment arms do not differ in terms of efficacy.

29 Jan 2014

G. Alexander Patterson honored with 2014 Earl Bakken Scientific Achievement Award

The Society of Thoracic Surgeons today awarded G. Alexander Patterson, MD with the 2014 Earl Bakken Scientific Achievement Award during the Society's 50th Annual Meeting.

28 Jan 2014

Everolimus fails to boost advanced NSCLC response

Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.

28 Jan 2014

Specific compounds found in exhaled breath may help diagnose lung cancer in early stages

Specific compounds found in exhaled breath may help diagnose lung cancer in its early stages, according to a study released today at the 50th Annual Meeting of The Society of Thoracic Surgeons.

28 Jan 2014

Top-line results from two Phase 3 studies of dacomitinib for patients with advanced NSCLC published

Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.

28 Jan 2014

BRAF mutations rare in Japanese NSCLC patients

Research in a Japanese cohort of patients with non-small-cell lung cancer indicates that the frequency of BRAF mutations is low and their presence has limited prognostic significance.

27 Jan 2014

Toshiba, AHRA announce recipients of 2013 Putting Patients First grant program

Helping facilities develop or improve existing education and patient care initiatives in diagnostic imaging, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the seven recipients of the sixth annual Putting Patients First grant program. Recipients were judged on their program plan and ability to share best practices for improving patient care and safety in CT, MR, Ultrasound, X-ray and Vascular imaging.

27 Jan 2014

Viewpoints: Consumers awakening to health law's 'perverse incentives;' Medicaid expansion could help Dems in mid-term elections; new 'devious tactic' in smoking

With fewer glitches to deter them, millions of Americans are now logging on to the ObamaCare health-insurance-exchange websites. When they get there, many are discovering some unpleasant surprises:

25 Jan 2014

Large-scale analysis of over 20 tumor types increases catalog of cancer genes by 25%

A landmark study across many cancer types reveals that the universe of cancer mutations is much bigger than previously thought. By analyzing the genomes of thousands of patients' tumors, a Broad Institute-led research team has discovered many new cancer genes - expanding the list of known genes tied to these cancers by 25 percent. Moreover, the study shows that many key cancer genes still remain to be discovered.

25 Jan 2014

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus gemcitabine as first-line therapy for patients with locally advanced and metastatic pancreatic adenocarcinoma.

25 Jan 2014

Immunotherapy maintenance shows promise in NSCLC

Results from a phase III trial have shown that tecemotide is no more effective than placebo as maintenance therapy in patients with non-small-cell lung cancer.

24 Jan 2014

Lung Cancer News and Research

Latest Lung Cancer News and Research

New combination MRI-ultrasound imaging system improves treatment for prostate cancer patients

Two oncogenes work together to sustain population of cells in lung squamous cell carcinoma

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Splicing findings offer lung cancer clues

Primary tumor, node location important in stage III NSCLC prognosis

Study describes new tack in treatment of lung adenocarcinomas

TSRI scientists awarded grant to develop new therapeutic approaches for lung cancer

American Cancer Society, SU2C partner to fight against cancer

New pre-clinical data shows potential protective effects of GFT505 in different types of cancer

EORTC study evaluates health-related quality of life assessment in small-cell lung cancer

G. Alexander Patterson honored with 2014 Earl Bakken Scientific Achievement Award

Everolimus fails to boost advanced NSCLC response

Specific compounds found in exhaled breath may help diagnose lung cancer in early stages

Top-line results from two Phase 3 studies of dacomitinib for patients with advanced NSCLC published

BRAF mutations rare in Japanese NSCLC patients

Toshiba, AHRA announce recipients of 2013 Putting Patients First grant program

Viewpoints: Consumers awakening to health law's 'perverse incentives;' Medicaid expansion could help Dems in mid-term elections; new 'devious tactic' in smoking

Large-scale analysis of over 20 tumor types increases catalog of cancer genes by 25%

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

Immunotherapy maintenance shows promise in NSCLC

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in